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Figure 1. Pathogenesis of HPV2 
HPV-Related Cancers 
Abstract 
Human Papillomavirus (HPV) is associated with more than 
150 viruses.1 HPV is an infection of the basal epithelium and 
transmission can occur either by direct contact or during 
childbirth. More than 50% of sexually active people will be 
infected with some form of HPV during their lifetime.2  Two 
categories of sexually transmitted HPV include low-risk 
HPVs, which are not cancer causing, and high-risk, or 
oncogenic HPVs, which can lead to a cancer diagnosis.  
Malignancies found to be associated with HPV infection 
include cervical, vaginal, vulvar, penile and anal cancers as 
well as cancers of the oropharynx. Treatment of HPV-related 
cancers often includes surgery, chemotherapy and radiation 
therapy. Health education and prevention is necessary to 
reduce cancers related to HPV infections. Education on 
abstinence and vaccinations are two methods proven to be 
effective. The role of the health care provider is to educate 
adolescents regarding the risk of sexually transmitted 
disease and ways to protect themselves from HPV-related 
cancers such as the cases reviewed in this exhibit.   
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Prevention   
Vaccination was approved for females between the ages of 9 
and 26 by the Food and Drug Administration in 2006 and for 
males in 2009 (Table 1). 
Both HPV vaccines currently available have proven efficacy 
for prevention of HPV vaccine type-related persistent infection 
and adenocarcinoma in-situ.3 Vaccination does not immunize 
against, or help clear prior viral exposure.4 
The efficacy drops precipitously in people previously exposed 
to HPV.  The only way to completely prevent getting HPV is 





The pathogenesis of HPV involves viral particles which 
enter the epithelial cells at areas of micro trauma, actively 
targeting proliferating basal cells.  As the infected cells 
migrate away from the basal layer, viral DNA is packaged 
into virions (infectious virus).  When the epithelium is shed, 
viral particles are released and are able to infect other cells 
(Figure 1).2 
Image 1. Treatment plan for tonsilar HPV-related cancer. 
Image 2. 3D reconstruction of anal HPV-related cancer. 
Case Study #1 
A 59 year old female presented with a sore throat & sinus 
issues for almost one year along with a right side neck mass.  
 
Histology revealed HPV-16 related squamous cell carcinoma 
of the tonsil measuring 5.8 cm.  The tumor was staged as  
T4a, N1, M0. 
 
Radiation therapy to a dose of 6000cGy  at 200cGy /fraction 
over 30 fractions was prescribed (Image 1).  The patient 
received two cycles of concurrent chemotherapy. 
 
Side effects included: Skin erythema, severe mucositis and 
constant xerostomia. 
 
Prognosis – HPV related H & N Cancers 
     HPV + 62% 5 year survival rate 
     HPV – 26% 5 year survival rate 
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Case Study #2 
A 72 year old female presented with a 3- 4 month history 
of weight loss of 30 lbs., diarrhea and pain while sitting. 
A CT of the pelvis revealed a large anorectal mass with 
extension into the lower pelvis measuring 14 x 10 x 8 cm.  
 
The histology report noted moderately differentiated 
squamous cell carcinoma & the tumor was staged as  
Stage cT4 cN0 cM0. 
 
Radiation therapy  to a total dose of 5580 cGy was 
prescribed at 180 cGy/fraction. The patient also received 
5FU and mytomycin C.  
 
Due to the large treatment field, as noted in Image 2, 
doses to the bowel and bladder were documented. Side 
effects included diarrhea, abdominal cramps and skin 
changes. 
 
Prognosis - 65% 5 year survival rate (all stages) 
Conclusion 
Each year, there are an estimated 26,000 HPV-attributable 
cancers in the United States. The CDC estimates that $8 
billion are spent yearly on direct medical costs for preventing 
and treating HPV-associated disease.6 Radiation therapy and 
chemotherapy contribute to this overall cost. Education at the 
adolescent/parental level is important to produce a decline in 
HPV-related malignancies.   
Table 1. Vaccination comparison 5 
